Applications of nanotechnology for immunology

por Smith, Douglas M., Simon, Jakub K., Baker Jr, James R.
Publicado 2013

Antibody-Based Correlates of Protection against Cholera: Analysis of a Challenge Study of a Cholera-Naive Population

por Haney, Douglas J., Lock, Michael D., Simon, Jakub K., Harris, Jason, Gurwith, Marc
Publicado 2017

A clinically parameterized mathematical model of Shigella immunity to inform vaccine design

por Davis, Courtney L., Wahid, Rezwanul, Toapanta, Franklin R., Simon, Jakub K., Sztein, Marcelo B.
Publicado 2018

Correction: A clinically parameterized mathematical model of Shigella immunity to inform vaccine design

por Davis, Courtney L., Wahid, Rezwanul, Toapanta, Franklin R., Simon, Jakub K., Sztein, Marcelo B.
Publicado 2018

Applying Mathematical Tools to Accelerate Vaccine Development: Modeling Shigella Immune Dynamics

por Davis, Courtney L., Wahid, Rezwanul, Toapanta, Franklin R., Simon, Jakub K., Sztein, Marcelo B., Levy, Doron
Publicado 2013

Association Between State Hepatitis A Vaccination Requirements and Hepatitis A Vaccination Rates

por Choi, Yoonyoung, Bhatti, Alexandra, Liu, Zhiwen, Ruch, Alex, Skolnik, Ava, Carias, Cristina, Goveia, Michelle G, Simon, Jakub K
Publicado 2022

Development of Pandemic Vaccines: ERVEBO Case Study

por Wolf, Jayanthi, Jannat, Risat, Dubey, Sheri, Troth, Sean, Onorato, Matthew T., Coller, Beth-Ann, Hanson, Mary E., Simon, Jakub K.
Publicado 2021

Gut-Homing Conventional Plasmablasts and CD27(−) Plasmablasts Elicited after a Short Time of Exposure to an Oral Live-Attenuated Shigella Vaccine Candidate in Humans

por Toapanta, Franklin R., Simon, Jakub K., Barry, Eileen M., Pasetti, Marcela F., Levine, Myron M., Kotloff, Karen L., Sztein, Marcelo B.
Publicado 2014

Immunogenicity, Lot Consistency, and Extended Safety of rVSVΔG-ZEBOV-GP Vaccine: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study in Healthy Adults

por Halperin, Scott A, Das, Rituparna, Onorato, Matthew T, Liu, Kenneth, Martin, Jason, Grant-Klein, Rebecca J, Nichols, Rick, Coller, Beth-Ann, Helmond, Frans A, Simon, Jakub K
Publicado 2019

Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in adults living with HIV

por Mohapi, Lerato, Pinedo, Yvett, Osiyemi, Olayemi, Supparatpinyo, Khuanchai, Ratanasuwan, Winai, Molina, Jean-Michel, Dagan, Ron, Tamms, Gretchen, Sterling, Tina, Zhang, Ying, Pedley, Alison, Hartzel, Jon, Kan, Yanqing, Hurtado, Kim, Musey, Luwy, Simon, Jakub K., Buchwald, Ulrike K.
Publicado 2022

rVSVΔG-ZEBOV-GP (also designated V920) recombinant vesicular stomatitis virus pseudotyped with Ebola Zaire Glycoprotein: Standardized template with key considerations for a risk/be...

por Monath, Thomas P., Fast, Patricia E., Modjarrad, Kayvon, Clarke, David K., Martin, Brian K., Fusco, Joan, Nichols, Richard, Heppner, D. Gray, Simon, Jakub K., Dubey, Sheri, Troth, Sean P., Wolf, Jayanthi, Singh, Vidisha, Coller, Beth-Ann, Robertson, James S.
Publicado 2019

Antibodies against the Ebola virus soluble glycoprotein are associated with long-term vaccine-mediated protection of non-human primates

por Gunn, Bronwyn M., McNamara, Ryan P., Wood, Lianna, Taylor, Sabian, Devadhasan, Anush, Guo, Wenyu, Das, Jishnu, Nilsson, Avlant, Shurtleff, Amy, Dubey, Sheri, Eichberg, Michael, Suscovich, Todd J., Saphire, Erica Ollmann, Lauffenburger, Douglas, Coller, Beth-Ann, Simon, Jakub K., Alter, Galit
Publicado 2023

Randomized, Placebo-Controlled, Double-Blind Phase 2 Trial Comparing the Reactogenicity and Immunogenicity of a Single Standard Dose to Those of a High Dose of CVD 103-HgR Live Att...

por Sow, Samba O., Tapia, Milagritos D., Chen, Wilbur H., Haidara, Fadima C., Kotloff, Karen L., Pasetti, Marcela F., Blackwelder, William C., Traoré, Awa, Tamboura, Boubou, Doumbia, Moussa, Diallo, Fatoumata, Coulibaly, Flanon, Onwuchekwa, Uma, Kodio, Mamoudou, Tennant, Sharon M., Reymann, Mardi, Lam, Diana F., Gurwith, Marc, Lock, Michael, Yonker, Thomas, Smith, Jonathan, Simon, Jakub K., Levine, Myron M.
Publicado 2017

Anti-O-specific polysaccharide (OSP) immune responses following vaccination with oral cholera vaccine CVD 103-HgR correlate with protection against cholera after infection with wil...

por Islam, Kamrul, Hossain, Motaher, Kelly, Meagan, Mayo Smith, Leslie M., Charles, Richelle C., Bhuiyan, Taufiqur Rahman, Kováč, Pavol, Xu, Peng, LaRocque, Regina C., Calderwood, Stephen B., Simon, Jakub K., Chen, Wilbur H., Haney, Douglas, Lock, Michael, Lyon, Caroline E., Kirkpatrick, Beth D., Cohen, Mitchell, Levine, Myron M., Gurwith, Marc, Harris, Jason B., Qadri, Firdausi, Ryan, Edward T.
Publicado 2018

Immune responses to O-specific polysaccharide (OSP) in North American adults infected with Vibrio cholerae O1 Inaba

por Hossain, Motaher, Islam, Kamrul, Kelly, Meagan, Mayo Smith, Leslie M., Charles, Richelle C., Weil, Ana A., Bhuiyan, Taufiqur Rahman, Kováč, Pavol, Xu, Peng, Calderwood, Stephen B., Simon, Jakub K., Chen, Wilbur H., Lock, Michael, Lyon, Caroline E., Kirkpatrick, Beth D., Cohen, Mitchell, Levine, Myron M., Gurwith, Marc, Leung, Daniel T., Azman, Andrew S., Harris, Jason B., Qadri, Firdausi, Ryan, Edward T.
Publicado 2019